Dong Guo

2.9k total citations
128 papers, 2.1k citations indexed

About

Dong Guo is a scholar working on Molecular Biology, Biomedical Engineering and Mechanical Engineering. According to data from OpenAlex, Dong Guo has authored 128 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 31 papers in Biomedical Engineering and 30 papers in Mechanical Engineering. Recurrent topics in Dong Guo's work include Receptor Mechanisms and Signaling (26 papers), Advanced Surface Polishing Techniques (25 papers) and Advanced machining processes and optimization (22 papers). Dong Guo is often cited by papers focused on Receptor Mechanisms and Signaling (26 papers), Advanced Surface Polishing Techniques (25 papers) and Advanced machining processes and optimization (22 papers). Dong Guo collaborates with scholars based in China, Netherlands and United Kingdom. Dong Guo's co-authors include Adriaan P. IJzerman, Laura H. Heitman, Thea Mulder‐Krieger, Xu Zhu, Ren Ke Kang, Yongsong Cao, Guanglong Ding, Tamara A. M. Mocking, Xingyu Wang and Juanli Zhu and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Dong Guo

117 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dong Guo China 26 1.1k 403 360 294 235 128 2.1k
Yuzheng Zhao China 31 2.0k 1.8× 271 0.7× 92 0.3× 176 0.6× 306 1.3× 93 3.2k
G. Sridhar Prasad United States 25 797 0.7× 199 0.5× 148 0.4× 152 0.5× 127 0.5× 53 2.4k
David Hepworth United Kingdom 26 962 0.9× 92 0.2× 616 1.7× 31 0.1× 175 0.7× 56 2.6k
Yibo Wang China 31 1.1k 1.0× 257 0.6× 361 1.0× 19 0.1× 407 1.7× 170 3.0k
Inchan Kwon South Korea 24 1.1k 1.0× 73 0.2× 271 0.8× 17 0.1× 328 1.4× 87 2.0k
Hailing Li China 31 966 0.9× 64 0.2× 337 0.9× 42 0.1× 217 0.9× 209 3.7k
Xin Xie China 31 1.0k 0.9× 71 0.2× 1.2k 3.3× 24 0.1× 158 0.7× 134 2.8k
Shanshan Qin China 26 581 0.5× 232 0.6× 119 0.3× 12 0.0× 573 2.4× 91 2.4k
Xiaokang Li China 25 741 0.7× 83 0.2× 276 0.8× 20 0.1× 308 1.3× 89 1.8k

Countries citing papers authored by Dong Guo

Since Specialization
Citations

This map shows the geographic impact of Dong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Guo more than expected).

Fields of papers citing papers by Dong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Guo. The network helps show where Dong Guo may publish in the future.

Co-authorship network of co-authors of Dong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Guo. A scholar is included among the top collaborators of Dong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Guo. Dong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Pei, Tian-Zi Hao, Zhitao Liu, et al.. (2025). Visible-light-induced dual catalysis for divergent reduction of nitro compounds with CO2 radical anion. Chinese Chemical Letters. 36(10). 110899–110899.
2.
Yang, Yueyue, Haiyang Zhong, Yanlian Li, et al.. (2025). Design of Selective BRD4 Inhibitors for the Treatment of Autosomal Dominant Polycystic Kidney Disease. Journal of Medicinal Chemistry. 68(5). 5257–5274. 2 indexed citations
3.
Liu, Hongli, Chongzhao You, Yixiao Zhang, et al.. (2025). Structural insights into antagonist recognition by the vasopressin V2 receptor. Nature Communications. 16(1). 9734–9734.
4.
Hu, Cheng, Yan Shen, Rumeng Zhang, et al.. (2025). Inhibiting mPGES-2 impedes renal cyst growth in mice with polycystic kidney disease. Acta Pharmacologica Sinica. 47(3). 689–700.
5.
Cai, Wenfeng, Peiying Li, Jian Li, et al.. (2025). De Novo Discovery of a Macrocyclic Peptide Antagonist of Interleukin-11 with Antirenal Fibrotic Efficacy. Journal of Medicinal Chemistry. 68(19). 20377–20388.
6.
Zhao, Na, Peiying Li, Jian Li, et al.. (2025). Development of a Long-Acting Interleukin-11 Antagonist for the Treatment of Renal Fibrosis. Journal of Medicinal Chemistry. 68(8). 8429–8438. 1 indexed citations
7.
Zhu, Xiaodan, et al.. (2025). Targeting TRAF6 inhibits cystogenesis in autosomal dominant polycystic kidney disease. Biochemical Pharmacology. 242(Pt 2). 117222–117222.
8.
Zhang, Xiang, et al.. (2024). Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications. Microbiological Research. 288. 127871–127871. 6 indexed citations
9.
Xu, Hui, et al.. (2024). Photocatalytic deuterocarboxylation of alkynes with oxalate. Chemical Science. 15(32). 13041–13048. 9 indexed citations
10.
Li, Jiajia, Haoran Zhang, Wenchao Zhao, et al.. (2024). Asymmetric synthesis of P-stereogenic phosphindane oxides via kinetic resolution and their biological activity. Nature Communications. 15(1). 2548–2548. 3 indexed citations
11.
Cao, Xudong, et al.. (2024). Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease. European Journal of Medicinal Chemistry. 271. 116428–116428. 6 indexed citations
12.
Chen, Ting, Hong-Tao Hu, Zifan Xu, et al.. (2024). Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development. Biochemical Pharmacology. 224. 116200–116200.
13.
Chen, Jiayuan, Yuyang Xie, Zhiheng Liu, et al.. (2023). Multi-omics profiling of cholangiocytes reveals sex-specific chromatin state dynamics during hepatic cystogenesis in polycystic liver disease. Journal of Hepatology. 78(4). 754–769. 6 indexed citations
14.
Guo, Dong & Adriaan P. IJzerman. (2017). Molecular Basis of Ligand Dissociation from G Protein-Coupled Receptors and Predicting Residence Time. Methods in molecular biology. 1705. 197–206. 4 indexed citations
15.
Massink, Arnault, Julien Louvel, Gabrielle S. Dijksteel, et al.. (2016). 5′-Substituted Amiloride Derivatives as Allosteric Modulators Binding in the Sodium Ion Pocket of the Adenosine A2AReceptor. Journal of Medicinal Chemistry. 59(10). 4769–4777. 26 indexed citations
16.
Hothersall, Joanne, Dong Guo, Sunil Sarda, et al.. (2016). Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics. Molecular Pharmacology. 91(1). 25–38. 22 indexed citations
17.
Guo, Dong, Albert C. Pan, Ron O. Dror, et al.. (2016). Molecular Basis of Ligand Dissociation from the Adenosine A2A Receptor. Molecular Pharmacology. 89(5). 485–491. 75 indexed citations
18.
Zhang, Wenbing, Tianyu Shi, Guanglong Ding, et al.. (2016). Nanosilica Schiff-Base Copper(II) Complexes with Sustainable Antimicrobial Activity against Bacteria and Reduced Risk of Harm to Plant and Environment. ACS Sustainable Chemistry & Engineering. 5(1). 502–509. 27 indexed citations
19.
Guo, Dong, Lizi Xia, Jacobus P. D. van Veldhoven, et al.. (2014). Binding Kinetics of ZM241385 Derivatives at the Human Adenosine A2A Receptor. ChemMedChem. 9(4). 752–761. 41 indexed citations
20.
Yang, Rui, et al.. (2012). Optimal Structural Frequency Design of Stiffened Shell. Applied Mechanics and Materials. 157-158. 1636–1639. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026